BioWorld Science

RSS

BMS claims beta3 agonists in patent literature

April 5, 1996

ACAT inhibitors claimed by DuPont Merck

April 5, 1996

Pierre Fabre reports hypocholesterolemic organosilanes

April 5, 1996

Vitronectin antagonist from Merck & Co. inhibits bone resorption

April 5, 1996

Cortecs licenses salmon calcitonin to Teva

April 5, 1996

Seed implant treatment effective in prostate cancer

April 5, 1996

Scotia accelerates development of temoporfin

April 5, 1996

Lu-Tex clinical update

April 5, 1996

New antitumor proteins from Alfacell

April 5, 1996

Oncogene Science, Pfizer extend research agreement

April 5, 1996